Phase I/II trial of preoperative TS-1 + CDDP + radiation therapy for large type 3 or type 4 advanced gastric cancer (OGSG 1205).

Trial Profile

Phase I/II trial of preoperative TS-1 + CDDP + radiation therapy for large type 3 or type 4 advanced gastric cancer (OGSG 1205).

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 25 Jan 2017

At a glance

  • Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
  • Indications Gastric cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Jan 2017 Planned End Date changed from 31 Dec 2020 to 31 Oct 2021.
    • 02 Oct 2016 Planned End Date changed from 31 Oct 2019 to 31 Dec 2020.
    • 09 Oct 2015 Planned end date changed from 31 Aug 2015 to 31 Oct 2019, as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top